Intestinal barrier integrity and inflammatory bowel disease: Stem cell-based approaches to regenerate the barrier

Journal of Tissue Engineering and Regenerative Medicine

Volumn 12, Issue 4, 2018, Pages 923-935

  Holmberg, Fredrik E O ^a   Pedersen, Jannie ^a   Jørgensen, Peter ^a   Soendergaard, Christoffer ^a   Jensen, Kim B ^b,c   Nielsen, Ole H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

antimicrobial peptides; inflammatory bowel disease; intestinal stem cells; mucus; pluripotent stem cells; tight junctions

Indexed keywords

BODY FLUIDS; CELL DEATH; DISEASES; MICROORGANISMS; PATIENT TREATMENT; PEPTIDES;

ANTIMICROBIAL PEPTIDE; CELL BASED APPROACHES; EPITHELIAL CELLS; INFLAMMATORY BOWEL DISEASE; INTESTINAL BARRIERS; INTESTINAL STEM CELL; MUCUS; PLURIPOTENT STEM CELLS; STEM-CELL; TIGHT JUNCTIONS;

STEM CELLS;

CROHN DISEASE; HEALING; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; INDUCED PLURIPOTENT STEM CELL; INFLAMMATORY BOWEL DISEASE; INTESTINAL STEM CELL; INTESTINE MUCOSA PERMEABILITY; MESENCHYMAL STEM CELL; MUCOSAL HEALING; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; ULCERATIVE COLITIS; WOUND HEALING; ANIMAL; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PLURIPOTENT STEM CELL; TRANSPLANTATION;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 85031749862     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.2506     Document Type: Review

References (137)

1. Ananthakrishnan, A. N., Weber, L. R., Knox, J. F., Skaros, S., Emmons, J., Lundeen, S., … Binion, D. G. (2008). Permanent work disability in Crohn's disease. American Journal of Gastroenterology, 103(1), 154–161.
2. Anokye-Danso, F., Trivedi, C. M., Juhr, D., Gupta, M., Cui, Z., Tian, Y., … Morrisey, E. E. (2011). Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8(4), 376–388.
3. Aoki, R., Shoshkes-Carmel, M., Gao, N., Shin, S., May, C. L., Golson, M. L., … Kaestner, K. H. (2016). Foxl1-expressing mesenchymal cells constitute the intestinal stem cell niche. Cellular and Molecular Gastroenterology and Hepatology, 2(2), 175–188.
4. Arnott, I. D., Kingstone, K., & Ghosh, S. (2000). Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scandinavian Journal of Gastroenterology, 35(11), 1163–1169.
5. Barker, N. (2014). Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration, Nature Reviews. Molecular Cell Biology, 15(1), 19–33.
6. Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., … Clevers, H. (2007). Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature, 449(7165), 1003–1007.
7. Beaugerie, L., & Itzkowitz, S. H. (2015). Cancers complicating inflammatory bowel disease. New England Journal of Medicine, 372(15), 1441–1452.
8. Beumer, J., & Clevers, H. (2016). Regulation and plasticity of intestinal stem cells during homeostasis and regeneration. Development, 143(20), 3639–3649.
9. Blander, J. M. (2016). Death in the intestinal epithelium-basic biology and implications for inflammatory bowel disease. FEBS Journal, 283(14), 2720–2730.
10. Blokzijl, F., de Ligt, J., Jager, M., Sasselli, V., Roerink, S., Sasaki, N., … van Boxtel, R. (2016). Tissue-specific mutation accumulation in human adult stem cells during life. Nature, 538(7264), 260–264.
11. Boal Carvalho, P., & Cotter, J. (2017). Mucosal healing in ulcerative colitis: a comprehensive review. Drugs, 77(2), 159–173.
12. Kersting, S., Bruewer, M., Schuermann, G., Klotz, A., Utech, M., Hansmerten, M., … Zimmer, K. P. (2004). Antigen transport and cytoskeletal characteristics of a distinct enterocyte population in inflammatory bowel diseases. The American Journal of Pathology, 165(2), 425–437.
13. Burisch, J., Jess, T., Martinato, M., Lakatos, P. L., & ECCO -EpiCom (2013). The burden of inflammatory bowel disease in Europe. Journal of Crohns Colitis, 7(4), 322–337.
14. Caliari, S. R., & Burdick, J. A. (2016). A practical guide to hydrogels for cell culture. Nature Methods, 13(5), 405–414.
15. Chen, J., Liu, J., Chen, Y., Yang, J., Chen, J., Liu, H., … Pei, D. (2011). Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics. Cell Research, 21(6), 884–894.
16. Cleynen, I., Vazeille, E., Artieda, M., Verspaget, H. W., Szczypiorska, M., Bringer, M. A., … Darfeuille-Michaud, A. (2014). Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut, 63(8), 1265–1274.
17. Corfield, A. P., Myerscough, N., Bradfield, N., Corfield, C. A., Gough, M., Clamp, J. R., … Williams, J. M. (1996). Colonic mucins in ulcerative colitis: evidence for loss of sulfation. Glycoconjugate Journal, 13(5), 809–822.
18. Coskun, M., Vermeire, S., & Nielsen, O. H. (2016). Novel targeted therapies for inflammatory bowel disease. Trends in Pharmacological Sciences, 38(2), 127–142.
19. Date, S., & Sato, T. (2015). Mini-gut organoids: reconstitution of the stem cell niche. Annual Review of Cell and Developmental Biology, 31, 269–289.
20. Di Sabatino, A., Ciccocioppo, R., Luinetti, O., Ricevuti, L., Morera, R., Cifone, M. G., … Corazza, G. R. (2003). Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Diseases of the Colon and Rectum, 46(11), 1498–1507.
21. Dorofeyev, A. E., Vasilenko, I. V., Rassokhina, O. A., & Kondratiuk, R. B. (2013). Mucosal barrier in ulcerative colitis and Crohn's disease. Gastroenterology Research and Practice, 2013, 431231.
22. Dotti, I., Mora-Buch, R., Ferrer-Picon, E., Planell, N., Jung, P., Masamunt, M. C., … Salas, A. (2016). Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. Gut. Epub ahead of print https://doi.org/10.1136/gutjnl-2016-312609
23. Dupont, A., Heinbockel, L., Brandenburg, K., & Hornef, M. W. (2014). Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa. Gut Microbes, 5(6), 761–765.
24. Duran, N. E., & Hommes, D. W. (2016). Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Therapeutic Advances in Gastroenterology, 9(4), 533–547.
25. Everhart, J. E., & Ruhl, C. E. (2009). Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology, 136(2), 376–386.
26. Fahlgren, A., Hammarström, S., Danielsson, A., & Hammarström, M. L. (2003). Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis. Clinical and Experimental Immunology, 131(1), 90–101.
27. Fahlgren, A., Hammarstrom, S., Danielsson, A., & Hammarstrom, M. L. (2004). beta-Defensin-3 and -4 in intestinal epithelial cells display increased mRNA expression in ulcerative colitis. Clinical and Experimental Immunology, 137(2), 379–385.
28. Farin, H. F., Jordens, I., Mosa, M. H., Basak, O., Korving, J., Tauriello, D. V., … Clevers, H. (2016). Visualization of a short-range Wnt gradient in the intestinal stem-cell niche. Nature, 530(7590), 340–343.
29. Fevr, T., Robine, S., Louvard, D., & Huelsken, J. (2007). Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Molecular and Cellular Biology, 27(21), 7551–7559.
30. Finkbeiner, S. R., Hill, D. R., Altheim, C. H., Dedhia, P. H., Taylor, M. J., Tsai, Y. H., … Spence, J. R. (2015). Transcriptome-wide analysis reveals hallmarks of human intestine development and maturation in vitro and in vivo. Stem Cell Reports, 4(6), 1140–1155.
31. Finkbeiner, S. R., & Spence, J. R. (2013). A gutsy task: generating intestinal tissue from human pluripotent stem cells. Digestive Diseases and Sciences, 58(5), 1176–1184.
32. Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., … Herrmann, R. P. (2014). A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association, 12(1), 64–71.
33. Fordham, R. P., Yui, S., Hannan, N. R., Soendergaard, C., Madgwick, A., Schweiger, P. J., … Jensen, K. B. (2013). Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell, 13(6), 734–744.
34. Frolkis, A. D., Dykeman, J., Negron, M. E., Debruyn, J., Jette, N., Fiest, K. M., … Kaplan, G. G. (2013). Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology, 145(5), 996–1006.
35. Gjorevski, N., Sachs, N., Manfrin, A., Giger, S., Bragina, M. E., Ordóñez-Morán, P., … Lutolf, M. P. (2016). Designer matrices for intestinal stem cell and organoid culture. Nature, 539(7630), 560–564.
36. Hama, T., Yamamoto, K., Yaguchi, Y., Murakami, D., Sasaki, H., Yamato, M., … Kojima, H. (2017). Autologous human nasal epithelial cell sheet using temperature-responsive culture insert for transplantation after middle ear surgery. Journal of Tissue Engineering and Regenerative Medicine, 11(4), 1089–1096.
37. Hawkey, C. J. (2012). Stem cells as treatment in inflammatory bowel disease. Digestive Diseases (Basel, Switzerland), 30(suppl 3), 134–139.
38. Heller, F., Florian, P., Bojarski, C., Richter, J., Christ, M., Hillenbrand, B., … Schulzke, J. D. (2005). Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology, 129(2), 550–564.
39. Hering, N. A., Fromm, M., & Schulzke, J. D. (2012). Determinants of colonic barrier function in inflammatory bowel disease and potential therapeutics. Journal of Physiology, 590(5), 1035–1044.
40. Holmberg, F. E. O., Seidelin, J. B., Yin, X., Mead, E. B., Tong, Z., Li, Y., … Nielsen, O. H. (2017). Culturing human intestinal stem cells for regenerative applications in the treatment of inflammatory bowel disease. EMBO Molecular Medicine, 9(5), 558–570.
41. Hughes, C. S., Postovit, L. M., & Lajoie, G. A. (2010). Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics, 10(9), 1886–1890.
42. Jabaji, Z., Brinkley, G. J., Khalil, H. A., Sears, C. M., Lei, N. Y., Lewis, M., … Dunn, J. C. (2014). Type I collagen as an extracellular matrix for the in vitro growth of human small intestinal epithelium. PLoS One, 9(9). e107814
43. Jäger, S., Stange, E. F., & Wehkamp, J. (2010). Antimicrobial peptides in gastrointestinal inflammation. International Journal of Inflammation, 2010, 910283.
44. Johansson, M. E. (2014). Mucus layers in inflammatory bowel disease. Inflammatory Bowel Disease, 20(11), 2124–2131.
45. Johansson, M. E., Sjovall, H., & Hansson, G. C. (2013). The gastrointestinal mucus system in health and disease. Nature Reviews. Gastroenterology and Hepatology, 10(6), 352–361.
46. Jung, P., Sato, T., Merlos-Suarez, A., Barriga, F. M., Iglesias, M., Rossell, D., … Batlle, E. (2011). Isolation and in vitro expansion of human colonic stem cells. Nature Medicine, 17(10), 1225–1227.
47. Jung, P., Sommer, C., Barriga, F. M., Buczacki, S. J., Hernando-Momblona, X., Sevillano, M., … Batlle, E. (2015). Isolation of human colon stem cells using surface expression of PTK7. Stem Cell Reports., 5(6), 979–987.
48. Kaplan, G. G., & Jess, T. (2016). The changing landscape of inflammatory bowel disease: east meets west. Gastroenterology, 150(1), 24–26.
49. Kelly, P., Feakins, R., Domizio, P., Murphy, J., Bevins, C., Wilson, J., & …Dhaliwal, W. (2004). Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clinical and Experimental Immunology, 135(2), 303–309.
50. Kiesslich, R., Duckworth, C. A., Moussata, D., Gloeckner, A., Lim, L. G., Goetz, M., … Watson, A. J. (2012). Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut, 61(8), 1146–1153.
51. Kim, J. M. (2014). Antimicrobial proteins in intestine and inflammatory bowel diseases. Intestinal Research, 12(1), 20–33.
52. Krausova, M., & Korinek, V. (2014). Wnt signaling in adult intestinal stem cells and cancer. Cellular Signalling, 26(3), 570–579.
53. Lee, D., Albenberg, L., Compher, C., Baldassano, R., Piccoli, D., Lewis, J. D., & Wu, G. D. (2015). Diet in the pathogenesis and treatment of inflammatory bowel diseases. Gastroenterology, 148(6), 1087–1106.
54. Lei, Y., Jeong, D., Xiao, J., & Schaffer, D. V. (2014). Developing defined and scalable 3D culture systems for culturing human pluripotent stem cells at high densities. Cellular and Molecular Bioengineering, 7(2), 172–183.
55. Lennon, G., Balfe, A., Bambury, N., Lavelle, A., Maguire, A., Docherty, N. G., … O'Connell, P. R. (2014). Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland, 16(5), O161–O169.
56. Li, N., Yousefi, M., Nakauka-Ddamba, A., Jain, R., Tobias, J., Epstein, J. A., … Lengner, C. J. (2014). Single-cell analysis of proxy reporter allele-marked epithelial cells establishes intestinal stem cell hierarchy. Stem Cell Reports, 3(5), 876–891.
57. Lindemans, C. A., Calafiore, M., Mertelsmann, A. M., O'Connor, M. H., Dudakov, J. A., Jenq, R. R., … Hanash, A. M. (2015). Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature, 528(7583), 560–564.
58. Luettig, J., Rosenthal, R., Barmeyer, C., & Schulzke, J. D. (2015). Claudin-2 as a mediator of leaky gut barrier during intestinal inflammation. Tissue Barriers, 3(1–2). e977176
59. Manieri, N. A., Drylewicz, M. R., Miyoshi, H., & Stappenbeck, T. S. (2012). Igf2bp1 is required for full induction of Ptgs2 mRNA in colonic mesenchymal stem cells in mice. Gastroenterology, 143(1), 110–121.
60. Marchiando, A. M., Shen, L., Graham, W. V., Edelblum, K. L., Duckworth, C. A., Guan, Y., … Watson, A. J. (2011). The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding. Gastroenterology, 140(4), 1208–1218.
61. Marks, P. W., Witten, C. M., & Califf, R. M. (2016). Clarifying stem-cell therapy's benefits and risks. New England Journal of Medicine, 376(11), 1007–1009.
62. McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H., & Radford-Smith, G. (2009). Intestinal barrier dysfunction in inflammatory bowel diseases. Inflammatory Bowel Disease, 15(1), 100–113.
63. Merga, Y., Campbell, B. J., & Rhodes, J. M. (2014). Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Digestive Diseases (Basel, Switzerland), 32(4), 475–483.
64. Middendorp, S., Schneeberger, K., Wiegerinck, C. L., Mokry, M., Akkerman, R. D., van Wijngaarden, S., … Nieuwenhuis, E. E. (2014). Adult stem cells in the small intestine are intrinsically programmed with their location-specific function. Stem Cells, 32(5), 1083–1091.
65. Miettinen, M., & Lasota, J. (2005). KIT (CD117)(): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Applied Immunohistochemistry & Molecular Morphology: AIMM / Official Publication of the Society for Applied Immunohistochemistry, 13(3), 205–220.
66. Mifflin, R. C., Pinchuk, I. V., Saada, J. I., & Powell, D. W. (2011). Intestinal myofibroblasts: targets for stem cell therapy. American Journal of Physiology. Gastrointestinal and Liver Physiology., 300(5), G684–G696.
67. Miyoshi, H. (2017). Wnt-expressing cells in the intestines: guides for tissue remodeling. Journal of Biochemistry, 161(1), 19–25.
68. Miyoshi, H., Ajima, R., Luo, C. T., Yamaguchi, T. P., & Stappenbeck, T. S. (2012). Wnt5a potentiates TGF-beta signaling to promote colonic crypt regeneration after tissue injury. Science, 338(6103), 108–113.
69. Miyoshi, H., VanDussen, K. L., Malvin, N. P., Ryu, S. H., Wang, Y., Sonnek, N. M., … Stappenbeck, T. S. (2017). Prostaglandin E2 promotes intestinal repair through an adaptive cellular response of the epithelium. EMBO Journal, 36(1), 5–24.
70. Molodecky, N. A., Soon, I. S., Rabi, D. M., Ghali, W. A., Ferris, M., Chernoff, G., … Kaplan, G. G. (2012). Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology, 142(1), 46–54.
71. Moon, C., VanDussen, K. L., Miyoshi, H., & Stappenbeck, T. S. (2014). Development of a primary mouse intestinal epithelial cell monolayer culture system to evaluate factors that modulate IgA transcytosis. Mucosal Immunology, 7(4), 818–828.
72. Muñoz, J., Stange, D. E., Schepers, A. G., van de Wetering, M., Koo, B. K., Itzkovitz, S., … Clevers, H. (2012). The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent '+4′ cell markers. EMBO Journal, 31(14), 3079–3091.
73. Nielsen, O. H., & Ainsworth, M. A. (2013). Tumor necrosis factor inhibitors for inflammatory bowel disease. New England Journal of Medince, 369(8), 754–762.
74. Nielsen, O. H., Coskun, M., Steenholdt, C., & Rogler, G. (2015). The role and advances of immunomodulator therapy for inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology, 9(2), 177–189.
75. Nielsen, O. H., Coskun, M., & Weiss, G. (2016). Iron replacement therapy: do we need new guidelines? Current Opinion in Gastroenterology, 32(2), 128–135.
76. Nielsen, O. H., Li, Y., Johansson-Lindbom, B., & Coskun, M. (2017). Sphingosine-1-phosphate signaling in inflammatory bowel disease. Trends in Molecular Medicine, 23(4), 362–374.
77. Okamoto, R., & Watanabe, M. (2005). Cellular and molecular mechanisms of the epithelial repair in IBD. Digestive Diseases and Sciences, 50(Suppl 1), S34–S38.
78. Okamoto, R., & Watanabe, M. (2016). Investigating cell therapy for inflammatory bowel disease. Expert Opinion on Biological Therapy, 16(8), 1015–1023.
79. Omardien, S., Brul, S., & Zaat, S. A. (2016). Antimicrobial activity of cationic antimicrobial peptides against gram-positives: current progress made in understanding the mode of action and the response of bacteria. Frontiers in Cell and Developmental Biology, 4, 111.
80. Panés, J., Garcia-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., … Danese, S. (2016). Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet, 388(10051), 1281–1290.
81. Pelaseyed, T., Bergström, J. H., Gustafsson, J. K., Ermund, A., Birchenough, G. M., Schutte, A., … Hansson, G. C. (2014). The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunology Reviews, 260(1), 8–20.
82. Pineton de Chambrum, G., Blanc, P., & Peyrin-Biroulet, L. (2016). Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology, 10(8), 915–927.
83. Planell, N., Lozano, J. J., Mora-Buch, R., Masamunt, M. C., Jimeno, M., Ordás, I., … Salas, A. (2013). Transcriptional analysis of the intestinal mucosa of patients with ulcerative colitis in remission reveals lasting epithelial cell alterations. Gut, 62(7), 967–976.
84. Pullan, R. D., Thomas, G. A., Rhodes, M., Newcombe, R. G., Williams, G. T., Allen, A., & Rhodes, J. (1994). Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut, 35(3), 353–359.
85. Qi, Z., Li, Y., Zhao, B., Xu, C., Liu, Y., Li, H., … Chen, Y. G. (2017). BMP restricts stemness of intestinal Lgr5+ stem cells by directly suppressing their signature genes. Nature Communications, 8, 13824.
86. Reinink, A. R., Lee, T. C., & Higgins, P. D. (2016). Endoscopic mucosal healing predicts favorable clinical outcomes in inflammatory bowel disease: a meta-analysis. Inflammatory Bowel Disease, 22(8), 1859–1869.
87. Reynolds, A., Wharton, N., Parris, A., Mitchell, E., Sobolewski, A., Kam, C., … Williams, M. R. (2014). Canonical Wnt signals combined with suppressed TGFbeta/BMP pathways promote renewal of the native human colonic epithelium. Gut, 63(4), 610–621.
88. Rieder, F., Brenmoehl, J., Leeb, S., Schölmerich, J., & Rogler, G. (2007). Wound healing and fibrosis in intestinal disease. Gut, 56, 130–139.
89. Rothenberg, M. E., Nusse, Y., Kalisky, T., Lee, J. J., Dalerba, P., Scheeren, F., … Clarke, M. F. (2012). Identification of a cKit(+) colonic crypt base secretory cell that supports Lgr5(+) stem cells in mice. Gastroenterology, 142(5), 1195–1205.
90. Sánchez de Medina, F., Romero-Calvo, I., Mascaraque, C., & Martinez-Augustin, O. (2014). Intestinal inflammation and mucosal barrier function. Inflammatory Bowel Disease, 20(12), 2394–2404.
91. Sangiorgi, E., & Capecchi, M. R. (2008). Bmi1 is expressed in vivo in intestinal stem cells. Nature Genetics, 40(7), 915–920.
92. Sasaki, N., Sachs, N., Wiebrands, K., Ellenbroek, S. I., Fumagalli, A., Lyubimova, A., … Clevers, H. (2016). Reg4+ deep crypt secretory cells function as epithelial niche for Lgr5+ stem cells in colon. Proceedings of the National Academy of Sciences of the United States of America, 113(37), E5399–E5407.
93. Sato, T., Stange, D. E., Ferrante, M., Vries, R. G., van Es, J. H., Van den Brink, S., … Clevers, H. (2011). Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology, 1415(5), 1762–1772.
94. Sato, T., van Es, J. H., Snippert, H. J., Stange, D. E., Vries, R. G., van den Born, M., … Clevers, H. (2011). Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature, 469(7330), 415–418.
95. Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., … Clevers, H. (2009). Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature, 459(7224), 262–265.
96. Schauber, J., Rieger, D., Weiler, F., Wehkamp, J., Eck, M., Fellermann, K., … Stange, E. F. (2006). Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases. European Journal of Gastroenterology and Hepatology, 18(6), 615–621.
97. Schmid, M., Fellermann, K., Fritz, P., Wiedow, O., Stange, E. F., & Wehkamp, J. (2007). Attenuated induction of epithelial and leukocyte serine antiproteases elafin and secretory leukocyte protease inhibitor in Crohn's disease. Journal of Leukocyte Biology, 81(4), 907–915.
98. Schulzke, J. D., Bojarski, C., Zeissig, S., Heller, F., Gitter, A. H., & Fromm, M. (2006). Disrupted barrier function through epithelial cell apoptosis. Annals of the New York Academy of Sciences, 1072, 288–299.
99. Schulzke, J. D., Ploeger, S., Amasheh, M., Fromm, A., Zeissig, S., Troeger, H., … Fromm, M. (2009). Epithelial tight junctions in intestinal inflammation. Annals of the New York Academy of Sciences, 1165, 294–300.
100. Scott, A., Rouch, J. D., Jabaji, Z., Khalil, H. A., Solorzano, S., Lewis, M., … Dunn, J. C. (2016). Long-term renewable human intestinal epithelial stem cells as monolayers: A potential for clinical use. Journal of Pediatric Surgery, 51(6), 995–1000.
101. Seidelin, J. B., Coskun, M., & Nielsen, O. H. (2013). Mucosal healing in ulcerative colitis: pathophysiology and pharmacology. Advances in Clinical Chemistry, 59, 101–123.
102. Shah, S. C., Colombel, J. F., Sands, B. E., & Narula, N. (2016). Mucosal healing is associated with improved long-term outcomes of patients with ulcerative colitis: a systematic review and meta-analysis. Clinical Gastroenterology and Hepatology: the Official Clinical Practice Journal of the American Gastroenterological Association, 14(9), 1245–1255.
103. Simms, L. A., Doecke, J. D., Walsh, M. D., Huang, N., Fowler, E. V., & Radford-Smith, G. L. (2008). Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease. Gut, 57(7), 903–910.
104. Soderholm, J. D., Streutker, C., Yang, P. C., Paterson, C., Singh, P. K., McKay, D. M., … Perdue, M. H. (2004). Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha. Gut, 53(12), 1817–1824.
105. de Souza, H. S., & Fiocchi, C. (2016). Immunopathogenesis of IBD: current state of the art. Nature Reviews. Gastroenterology and Hepatology, 13(1), 13–27.
106. Spence, J. R., Mayhew, C. N., Rankin, S. A., Kuhar, M. F., Vallance, J. E., Tolle, K., … Wells, J. M. (2011). Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature, 470(7332), 105–109.
107. Strugala, V., Dettmar, P. W., & Pearson, J. P. (2008). Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease. International Journal of Clinical Practice, 62(5), 762–769.
108. Sturm, A., & Dignass, A. U. (2008). Epithelial restitution and wound healing in inflammatory bowel disease. World Journal of Gastroenterology, 14(3), 348–353.
109. Sun, J., Shen, X., Li, Y., Guo, Z., Zhu, W., Zuo, L., … Li, J. (2016). Therapeutic potential to modify the mucus barrier in inflammatory bowel disease. Nutrients, 8(1), 44–58.
110. Symonds, D. A. (1974). Paneth cell metaplasia in diseases of the colon and rectum. Archives of Pathology, 97(6), 343–347.
111. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.
112. Takeda, N., Jain, R., LeBoeuf, M. R., Wang, Q., Lu, M. M., & Epstein, J. A. (2011). Interconversion between intestinal stem cell populations in distinct niches. Science, 334(6061), 1420–1424.
113. Tanaka, F., Tominaga, K., Ochi, M., Tanigawa, T., Watanabe, T., Fujiwara, Y., … Arakawa, T. (2008). Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sciences, 83(23–24), 771–779.
114. Tekkatte, C., Gunasingh, G. P., Cherian, K. M., & Sankaranarayanan, K. (2011). "Humanized" stem cell culture techniques(): the animal serum controversy. Stem Cells International, 2011. 504723
115. Tetteh, P. W., Basak, O., Farin, H. F., Wiebrands, K., Kretzschmar, K., Begthel, H., … Clevers, H. (2016). Replacement of lost Lgr5-positive stem cells through plasticity of their enterocyte-lineage daughters. Cell Stem Cell, 18(2), 203–213.
116. Theodoratou, E., Campbell, H., Ventham, N. T., Kolarich, D., Pucic-Bakovic, M., Zoldos, V., … Lauc, G. (2014). The role of glycosylation in IBD. Nature Reviews. Gastroenterology and Hepatology, 11(10), 588–600.
117. Tong, Z., Solanki, A., Hamilos, A., Levy, O., Wen, K., Yin, X., & Karp, J. M. (2015). Application of biomaterials to advance induced pluripotent stem cell research and therapy. EMBO Journal, 34(8), 987–1008.
118. Turner, J. R. (2009). Intestinal mucosal barrier function in health and disease. Nature Reviews. Immunology, 9(11), 799–809.
119. Van Beelen Granlund, A., Ostvik, A. E., Brenna, O., Torp, S. H., Gustafsson, B. I., & Sandvik, A. K. (2013). REG gene expression in inflamed and healthy colon mucosa explored by in situ hybridisation. Cell and Tissue Research, 352(3), 639–646.
120. Van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., … Clevers, H. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111(2), 241–250.
121. Van der Flier, L. G., Haegebarth, A., Stange, D. E., van de Wetering, M., & Clevers, H. (2009). OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology, 137(1), 15–17.
122. Van der Flier, L. G., van Gijn, M. E., Hatzis, P., Kujala, P., Haegebarth, A., Stange, D. E., … Clevers, H. (2009). Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell, 136(5), 903–912.
123. Van Es, J. H., Sato, T., van de Wetering, M., Lyubimova, A., Nee, A. N., Gregorieff, A., … Clevers, H. (2012). Dll1+ secretory progenitor cells revert to stem cells upon crypt damage. Nature Cell Biology, 14(10), 1099–1104.
124. Wang, Y., Wang, B., Wu, J., Jiang, X., Tang, H., & Nielsen, O. H. (2017). Modulation of gut microbiota in pathological states. Engineering, 3(1), 83–89.
125. Wang, X., Yamamoto, Y., Wilson, L. H., Zhang, T., Howitt, B. E., Farrow, M. A., … Xian, W. (2015). Cloning and variation of ground state intestinal stem cells. Nature, 522(7555), 173–178.
126. Watson, C. L., Mahe, M. M., Munera, J., Howell, J. C., Sundaram, N., Poling, H. M., … Helmrath, M. A. (2014). An in vivo model of human small intestine using pluripotent stem cells. Nature Medicine, 20(11), 1310–1314.
127. Wehkamp, J., Chu, H., Shen, B., Feathers, R. W., Kays, R. J., Lee, S. K., & Bevins, C. L. (2006). Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Letters, 580(22), 5344–5350.
128. Wehkamp, J., Fellermann, K., Herrlinger, K. R., Baxmann, S., Schmidt, K., Schwind, B., … Stange, E. F. (2002). Human beta-defensin 2 but not beta-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. European Journal of Gastroenterology and Hepatology, 14(7), 745–752.
129. Wehkamp, J., Harder, J., Weichenthal, M., Mueller, O., Herrlinger, K. R., Fellermann, K., … Stange, E. F. (2003). Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflammatory Bowel Disease, 9(4), 215–223.
130. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaffeler, E., Schlee, M., … Stange, E. F. (2004). NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression. Gut, 53(11), 1658–1664.
131. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., … Bevins, C. L. (2005). Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proceedings of the National Academy of Sciences of the United States of America, 102(50), 18129–18134.
132. Workman, M. J., Mahe, M. M., Trisno, S., Poling, H. M., Watson, C. L., Sundaram, N., … Wells, J. M. (2016). Engineered human pluripotent-stem-cell-derived intestinal tissues with a functional enteric nervous system. Nature Mediicine, 23(1), 49–59.
133. Yabana, T., Arimura, Y., Tanaka, H., Goto, A., Hosokawa, M., Nagaishi, K., … Shinomura, Y. (2009). Enhancing epithelial engraftment of rat mesenchymal stem cells restores epithelial barrier integrity. Journal of Pathology, 218(3), 350–359.
134. Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324(5928), 797–801.
135. Yui, S., Nakamura, T., Sato, T., Nemoto, Y., Mizutani, T., Zheng, X., … Watanabe, M. (2012). Functional engraftment of colon epithelium expanded in vitro from a single adult Lgr5(+) stem cell. Nature Medicine, 18(4), 618–623.
136. Zeissig, S., Burgel, N., Gunzel, D., Richter, J., Mankertz, J., Wahnschaffe, U., … Schulzke, J. D. (2007). Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut, 56(1), 61–72.
137. Zhang, S., Ermann, J., Succi, M. D., Zhou, A., Hamilton, M. J., Cao, B., … Karp, J. M. (2015). An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Science Translation Med, 7(300). 300ra128